Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease

E. Lawitz, F. Poordad, J. A. Gutierrez, T. N. Kakuda, G. Picchio, G. Beets, A. Vandevoorde, P. Van Remoortere, B. Jacquemyn, D. Luo, S. Ouwerkerk-Mahadevan, L. Vijgen, V. Van Eygen, M. Beumont

Research output: Contribution to journalArticle

16 Scopus citations

Fingerprint Dive into the research topics of 'Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease'. Together they form a unique fingerprint.

Medicine & Life Sciences